Objectives: Shortage of donors is one of the major limitations in lung transplantation (LuTX) and an aggressive expansion of criteria for donor selection has been proposed. This study evaluates the outcome of recipients of pulmonary grafts coming from resuscitated donors when compared with recipients of non-resuscitated donors. Methods: We retrospectively analyzed the donor and recipient charts of all double LuTX performed at our institution between 2000 and 2008 with regard to the performance of donor-cardiopulmonary resuscitation (CPR). Results: Out of 186 eligible transplants, 22 patients (11.8%) received lungs from donors who have suffered cardiac arrest (CA) and subsequent CPR. Mean duration of CPR was 15.2 AE 11.3 min. Terminal laboratory profiles of CPR donors and non-CPR donors were similar as were ventilation time and paO 2 /FiO 2 ratio before organ harvesting or chest X-ray. CPR-donor status did not affect the following indices of graft function: length of postoperative ventilation, paO 2 / FiO 2 ratio up to 48 h and lung function up to 60 months. Length of intensive care and hospital stay, need for inotropic support and 30-day mortality were not significantly different for the transplantation of CPR or no-CPR donor lungs. One-and 3-year survival rates were comparable as well with 84.4% and 66.3% for CPR donors versus 88.5% and 69.8% no-CPR donors. Conclusions: This study indicates that transplantation of lungs from resuscitated donors may not affect outcome after LuTX. Therefore, donor history of CA should not automatically preclude LuTX. #
Introduction
Lung transplantation (LuTX) has been established as a treatment option for end-stage pulmonary disease [1] . Despite increasing numbers of transplants performed, the demand for donor lungs clearly exceeds the supply. Although allocations systems are modified to improve organ shortage, it is still a major issue with significant mortality on the lungtransplant waiting list [2] .
Strategies to increase the number of suitable lung donors include donor management, non-heart beating donor, livingrelated LuTX and volume reduction surgery of the donor organ to overcome size disparities [3] [4] [5] .
According to presently accepted criteria, only about 20% of multi-organ donor lungs are considered to be suitable for transplantation [4] . These traditional criteria for optimal donor lungs derived from small volume studies performed in the early area of lung transplantation. Therefore, an expansion of criteria for donor selection has been proposed [6] . However, discussion about the liberalization of donor selection criteria and its effect on outcome remains a controversy [7] . History of cardiac arrest (CA) and cardiopulmonary resuscitation (CPR) is frequently a reason for refusal of lungs for transplantation, despite scientific evidence being still missing [8] . Although CA with subsequent resuscitation might cause global ischemia to all organs, studies could show that acceptance of hepatic or intestinal organs after donor CPR may not increase the risk of transplantation [9, 10] .
In addition, temporary ischemia during CA might have beneficial effects on the lung, for example, potentially triggering ischemic preconditioning (IP) with reduced ischemia-reperfusion (IR) injury [10] .
Therefore, it was the aim of this study to evaluate the impact of history of donor CA and subsequent CPR on outcome in lung transplantation.
Material and methods

Patients
Between 1 January 2000 and 31 December 2008, data were collected on all consecutive double-lung transplantations at our University Hospital. A retrospective analysis was then performed. Patients were divided into two groups: recipients of lungs from donors, who suffered cardiopulmonary arrest and resuscitation and recipients of non-resuscitated donors.
Donor acceptance
All donors were assessed for acceptability for transplantation by either the lung-transplant fellow or the staff lungtransplant surgeon. A donor management protocol was performed as soon as possible including early bronchoscopy, diuretics, antibiosis and optimized ventilation. Donor lungs were assessed by bronchoscopy, chest X-ray (CXR), laboratory work and medical history. Macroscopic and bronchoscopic inspection was finally performed by the retrieving surgeon. Lung function before harvest was based on final paO 2 /FiO 2 ratio in the operating room. Chest trauma was defined as finding of a pneumothorax or contusion on CXR or by macroscopic assessment of the lung showing signs of contusion. Lung procurement and preservation followed standard procedures with cold PerfadexSolution for anterograde and retrograde flushing. The technical details for the LuTX procedure have been described elsewhere [11] .
LuTX procedure and postoperative care
All bilateral LuTXs were performed with standard use of cardiopulmonary bypass for controlled reperfusion. Immunosuppression was based on a triple therapy (cyclosporine, mycophenolate mofetil and prednisolone). Prophylaxis for Pneumocystis carinii and cytomegalovirus infection was achieved with low-dose oral thrimethroprim-sulphamethoxazole and ganciclovir, respectively, dependent on the risk profile. Standardized evaluation for rejection and infection included clinical assessment, CXR and pulmonary function test. Bronchoscopy was performed routinely in the immediate postoperative period and was performed subsequently for clinical symptoms or spirometric evidence of allograft dysfunction. Surveillance bronchoscopy and transbronchial biopsies were performed after 4-8 weeks, and after 3, 6, 9 and 12 months in the absence of symptoms.
Database
All information acquired during the patients' surveillance was transferred to our institutional database. Data entered could be retrieved at any time by transplantation personnel with filtering and sorting as needed.
Resuscitated and non-resuscitated donor were compared with regard to initial graft function assessed by paO 2 /FiO 2 ratio at arrival to the intensive care unit (ICU), on postoperative day 1 and 2; length of mechanical ventilation; ICU lengths of stay, time to hospital discharge, need for inotropic support 48 h post-LuTX, spirometric lung function up to 36 months after LuTX; survival after 30 days, 1, 3 and 5 years. Graft ischemic time of bilateral LuTX in our study was defined as the average value of the ischemic time for the first and second transplanted lung.
Statistical analysis
Statistical analyses were performed with Sigma-Stat 2.03 (SPPS Inc., Chicago, IL, USA). Continuous data were expressed as mean AE standard deviation; categorical data were expressed as percentage. Confidence interval for the means of both study groups was calculated with a confidence level of 98%. Comparisons between two groups were carried out using unpaired Student's t-test for normally or the MannWhitney Rank Sum Test for non-normally distributed data. Multiple groups were compared with analysis of variance (ANOVA). Correlations were calculated with Pearson's Product Moment Correlation or with Spearman's Rank Order Correlation, depending on skewness and distribution of data. The probability of observed categorical variables was determined with Fisher's exact test. Patients' survival rates were estimated with the Kaplan-Meier product-limit method; comparison of survival was carried out by using the log-rank-test. Statistical significance was assumed for a p-value < 0.05.
Results
Donor and recipient data
Between 2000 and 2008, 186 double LuTXs were performed at our institution. Out of these, we identified 22 recipients (11.8%) who received lungs from a donor with history of CA and subsequent CPR. Mean duration of CPR was 15.2 AE 11.3 min, mean interval between CPR and transplantation was 57.78 AE 34.73 h. Table 1 compares several donor-related variables between the two groups. There was no statistical difference between the group of CPR donors and the group of no-CPR donors in terms of gender, age, cytomegalovirus (CMV) status or cause of death. In addition, donor organ assessment criteria including bronchoscopy and radiologic findings, incidence of chest trauma, duration of mechanical ventilation and oxygenation were similar. Terminal laboratory findings, including sodium, creatinine, aspartate aminotransferase and alanine aminotransferase, did not differ between the two groups. In addition, the need for blood transfusion or vasopressor therapy was comparable between the two groups. Table 2 shows recipient characteristics including the indication for LuTX. The most common reason for transplantation was emphysema, followed by pulmonary fibrosis. Severity of illness indicated by mean duration of waiting time, incidence of high urgency status or preoperative mechanical ventilation and results of the 6-minwalk-test did not show any differences. Recipient risk profile, for example, CMV or gender mismatch were comparable as well.
Parameters after LuTX
The outcome after LuTX regarding several end points is summarized in Table 3 with comparable postoperative results in both groups in a univariate analysis. There were no statistical differences between the two groups in terms of operative variables, such as ischemic time and bypass time or hospital course (length of postoperative ventilation, length of ICU stay or hospital stay and need for inotropes).
Initial graft function assessed by the oxygenation capacity of the lung from arrival at the ICU up to 48 h after transplantation was comparable in the two groups with an initial paO 2 /FiO 2 ratio of 531 AE 144 mm Hg for CPR donors versus 435 AE 218 mm Hg for no-CPR donors. Lung function in spirometry up to 3 years after transplantation showed stable values and did not differ between the two groups. One-and 3-year survival was comparable with 84.4% and 66.3% for CPR donors versus 88.5% and 69.8% for no-CPR donors (Fig. 1) . Five-year-survival tended to be lower in the CPR group but did not reach statistical significance (53.2% vs 37.3%).
Causes of death and number of graft-related deaths did not differ between the groups (Table 4 ).
An acute rejection episode with the necessity of steroid therapy was observed in four patients of the CPR group (18.2%) and in 36 patients of the no-CPR group (21.9%). Occurrence of bronchiolitis obliterans of any grade after 5 years was diagnosed in eight patients of the CPR group (36.4%) versus 53 patients in the no-CPR group (32.3%) without reaching significance.
Discussion
In a retrospective evaluation of our single center LuTX database, we found that use of donor lungs with a history of CA and subsequent CPR increased the number of transplants performed at our institution without compromising longterm outcome in our lung recipients. We found no significant difference in initial graft function, hospital course, pulmonary function and survival after 5 years.
Recent improvements in surgical technique, organ preservation and immunosuppressive therapy have established LuTX as a therapeutical option for end-stage pulmonary disease [1] . Still, due to shortage of donor organs, an imbalance between demand and supply is evident. Nonetheless, only a minority of potential multi-organ donors are used for lung donation [4] . The situation is even worse, when the donor has a history of CA and CPR, thus further reducing the recovery rate for thoracic organs in multi-organ donors with CA [8] . In fact, CA might lead to some adverse effects, including tissue hypoperfusion due to global ischemiadepending on the duration of CA and promptness and effectiveness of resuscitation. It has been suggested that organ donors with one episode of CA are prone to greater hemodynamic instability and, therefore, lower rates of organ recovery [12, 13] . However, up till date, the decision process for the lung is based more on individual opinions and experiences than on existing evidence, in particular because traditional criteria do not include CPR status. The question of whether or not donors with CA could potentially expand the donor pool without compromising the results has not been answered yet and was the aim of our study. CA is followed by an inflammatory response that is associated with multiple adverse effects on hemodynamics, vascular reactivity, immunology and the coagulation systemthe so-called post-resuscitation syndrome [14] . High levels of circulating cytokines and adhesion molecules, the presence of plasma endotoxin, dysregulated leukocyte production of cytokines and reactive oxygen species might impair pulmonary function. Our data reveal a delay of 3 days from CPR to procurement, suggesting a possible stabilization of hemodynamics and laboratory values before procurement. Our findings of a comparable number of vasopressors and hemodynamics before procurement as well as sodium levels in the two study groups support this hypothesis. Wilson et al. found similar results in LuTX with a rather increased time of CA compared with our data [10] . Others confirmed this in intestinal transplantation [9] . Recent studies in heart transplantation reported good results with hearts from CPR donors [15] . On the other hand, Keitel et al. reported that CPR of the organ donor has been associated with overall poor donor quality in kidney transplantation, demonstrating a difference in tolerance of different organs exposed to CA [16] .
Our results show that lungs from donors after CA and CPR do not compromise long-term results after transplantation up to 5 years after transplantation. As objective donor assessment criteria and number of extended donors in each group were comparable, donor selection by an experienced lung-transplant surgeon may have excluded those donors who suffered from lung injury due to CA and resuscitation. Therefore, we cannot rule out that CA might have an impact on lung function in some cases, but this effect is not apparent in our study as those affected lungs were probably refused for transplant as well as lungs presenting with edema in the chest X-ray or bronchoscopic abnormalities. In addition, optimal donor management might -at least partly -have compensated [ ( ) T D $ F I G ] Fig. 1 . Kaplan-Meier-survival curve for both study groups. Table 4 . Cause of death after transplantation.
Cause of death after LuTX (n = 61)
No CPR (n = 53)
p-Value
Sepsis/multi-organ failure (n, %) 4 (50) 29 (55) n.s
Acute graft failure (n, %) 1 (13) 7 (13) n.s Carcinoma (n, %) 0 (0) 3 (6) n.s Cardiac/hemodynamic complications (n, %)
1 (13) 6 (11) n.s.
Neurological complications (n, %) negative effects of CA. Blood gas analysis before procurement revealed good oxygenation capacity in both groups, suggesting an uncompromised lung function, at least in the early phase after CPR. Therefore, CA with CPR seems not to induce IR injury. This is of special importance, as graft failure due to IR injury remains one major cause for mortality [17] . In addition to its nonspecific effects, it potentiates graft immunogenicity and increases risk of early and late rejection. We did not find any difference between the groups in terms of acute or chronic rejection.
Temporary ischemia during CA might have beneficial effects, for example, triggering IP, thereby protecting the graft from IR injury [10] . IP is a well-established phenomenon that describes tissue adaptation to stress by taking advantage of intrinsic defense mechanisms that confer a more resistant status upon tissues [18] . It consists of a short period of ischemia followed by reperfusion, which protects from subsequent severe ischemia/reperfusion. Recent reports confirm the efficacy of preconditioning in cardiac surgery and percutaneous coronary interventions in humans [19, 20] . IP uses endogenous as well as distant mechanisms in skeletal muscle, liver, kidney, intestine and brain in animal models. However, there are limited data on similar effects on the lung. In different animal models, it was found that IP, by blocking the pulmonary hilar blood flow, could attenuate the pulmonary dysfunction related to exposure to subsequent I/R [21] .
From studies in myocardium, two windows of protection can be distinguished in IP: an early protective effect named classical IP and a delayed phase of resistance known as second window of protection (SWOP), also referred as delayed or late IP [18, 22] . Classical or early IP protection was first described in 1986 by Murry et al. in the heart [18] . It is transient, present for about 2 h following the procedure, disappearing beyond 4 h. SWOP was first described in 1993 by Kuzuya et al. and Marber et al., who discovered this delayed phase of myocardial protection [22] . Late IP appears about 12 h after the initial IP stimulus, is long-lasting, and persisting up to 72 h -but not as powerful as the early phase. In our group, the mean time of CPR to procurement was 57 h, suggesting a possible SWOP effect of IP, if it exists in the lung. However, this is a matter of speculation and, if applicable, might be connected with another phenomenon called remote conditioning [23, 24] . Global ischemia due to CA in multi-organ donors might protect transplanted organs from IR injury. In our analysis, an effect such as remote conditioning could not be found, as indicated by comparable early outcome data (intubation hours, oxygenation capacity). It has to be mentioned that we did not perform any specific studies such as serial histology to quantify IR injury. Therefore, a potential benefit might not be apparent in our study and this might necessitate an analysis on a cellular level in further studies.
Organ implantation was performed under cardiopulmonary bypass support in all cases as the occurrence of IR injury, in general, is clearly diminished in our experience. Use of cardiopulmonary bypass for LuTX is still under discussion. However, the reported advantages consist of safeguarding circulation and gas exchange of the recipient, preventing early hyperperfusion of the first implanted graft, and, most importantly, controlling reperfusion and ameliorating IR injury to both implanted grafts [25] .
There are some limitations in our study. Due to the relative small number of donors in the CPR group, the power to detect a difference in outcome between groups is limited. This applies in particular for long-term-outcome data, for example, 5-year survival rates. In addition, the retrospective study design and evaluation of a single center database restrict the evidence level. The observations made in this article may be influenced by preselection of donors, artificially affecting the results after transplantation, as we could not consider all the potential CPR donors that have not been used for transplantation. Therefore, our findings, especially regarding long-term follow-up, have to be confirmed in a prospective multicenter study.
In summary, we could show that transplantation of lungs from resuscitated donors may not affect outcome, when these cases are carefully selected and otherwise fulfill classical donor criteria. Our experiences in the lung and those of others in heart, liver or intestinal transplantation demonstrate the usefulness of thorough evaluation of the resuscitated donor. History of cardiopulmonary arrest should not preclude LuTX. Individual evaluation and risk stratification by an experienced lung-transplant team is necessary to identify suitable donors that can be transplanted successfully.
